Strattera (Atomoxetine) for ADHD: What to Expect

Strattera is the ADHD medication people often hear about after a stimulant did not suit them, or when they ask whether there is an option that is not a stimulant at all. The generic name is atomoxetine, and it works differently enough from Adderall or Ritalin that the usual expectations do not fit.

A quick note on where this comes from. I live in Turkey and I am not a doctor. This is a research-based explainer, built from the current FDA label and published studies, not from my own use. Whether atomoxetine is right for you, and at what dose, is a decision for you and your prescriber.

What Strattera is

Atomoxetine was first approved in the US in 2002. Its FDA label describes it as a selective norepinephrine reuptake inhibitor (SNRI) for treating ADHD in adults and in children 6 years and older.

Three facts set it apart from most ADHD medications:

• It is not a stimulant. The label states plainly that atomoxetine is not a controlled substance.
• It works gradually. It builds up over weeks instead of switching on within an hour.
• It is available as a generic. Besides brand-name Strattera, DailyMed lists generic atomoxetine capsules from many manufacturers (checked October 23, 2026).

If you want to see where it sits among all the options, the list of ADHD medications lays out the full picture, and the guide to non-stimulant ADHD medications compares atomoxetine with its closest relatives.

How atomoxetine works

Norepinephrine is one of the brain's chemical messengers, involved in attention, alertness and the ability to hold a goal in mind. After it sends its signal, a transporter pulls it back into the nerve cell. Atomoxetine blocks that transporter, so norepinephrine stays active a little longer.

The label is honest that the exact mechanism behind its effect on ADHD is unknown. It is thought to come from this blocking of the norepinephrine transporter.

Stimulants work on dopamine and norepinephrine together and produce an effect within the same day. If you are curious about that contrast, the guide to what Adderall is covers the stimulant side.

How long Strattera takes to work

This is the part that surprises people most, and the part where expectations matter.

A stimulant can be judged within days. Atomoxetine cannot. A 2015 review of the trial data by Clemow and Bushe found that it can start working within one to two weeks, but that response keeps increasing gradually for up to 24 weeks or longer. That review was written by scientists employed by Eli Lilly, the company that makes Strattera, which is worth knowing when you read it. Its timeline still matches what the label's own trials show: the adult studies that established effectiveness lasted 10 weeks, not one.

The same review notes that a single daily dose can cover a full 24 hours, even though the drug's half-life in most people is only about five hours. So there is usually no clear wearing-off moment in the afternoon the way there can be with a stimulant.

Time on atomoxetine	What is typical
First days	Little ADHD benefit yet. Side effects such as nausea or tiredness may show up first.
Weeks 1 to 2	Some people notice early changes.
Weeks 2 to 12	The dose is adjusted and the effect builds. Most trials measured results somewhere in this window.
Months 3 to 6	Response can continue to improve gradually.

The site's article on how long ADHD medication takes to work compares these timelines across medication types.

Who it may be considered for

The label does not rank atomoxetine against other medications, and the choice depends on your history. Situations where it commonly comes up in a conversation with a prescriber include:

• a stimulant caused side effects that could not be managed,
• there is a history of substance misuse and a non-controlled option is preferred,
• anxiety is part of the picture (more on that below),
• you want steady coverage through the whole day, including evenings.

It is also worth being clear about the trade-off. In the large 2018 network meta-analysis by Cortese and colleagues, atomoxetine worked better than placebo in both children and adults. In head-to-head comparisons, though, amphetamines came out more effective than atomoxetine on clinician ratings. For adults, the benefit of atomoxetine and methylphenidate looked similar in size. In children, methylphenidate showed a larger effect.

Common side effects

The label lists the side effects that appeared most often in clinical trials. For adults, here are the most frequent ones, compared with placebo:

Side effect (adults)	Atomoxetine	Placebo
Nausea	26%	6%
Dry mouth	20%	5%
Decreased appetite	16%	3%
Insomnia	15%	8%
Fatigue	10%	6%
Constipation	8%	3%
Dizziness	8%	3%
Erectile dysfunction	8%	1%
Urinary hesitation	6%	1%

In children and teens, the most common were nausea, vomiting, tiredness, decreased appetite, stomach pain and sleepiness. Because of the sleepiness, the label advises caution with driving or operating machinery until you know how it affects you.

Some people metabolize atomoxetine much more slowly because of a variation in a liver enzyme called CYP2D6. In these poor metabolizers, the half-life is around 22 hours instead of 5, and side effects like insomnia and tremor showed up more often in trials. Certain antidepressants that block the same enzyme, such as fluoxetine and paroxetine, can raise atomoxetine levels several times over. This is one reason your prescriber needs your full medication list.

For general patterns that apply across ADHD medications, see ADHD medication side effects.

The boxed warning: suicidal thoughts in children and teens

Strattera carries a boxed warning, the strongest kind of warning the FDA puts on a label. In the 2026 label, it is titled "Suicidal Thoughts and Behaviors in Pediatric Patients 6 Years of Age and Older."

Here is what the data behind it shows. In a pooled analysis of 12 short-term studies (6 to 18 weeks) with over 2,200 children and teens, 11 of them in ADHD, suicidal thoughts were reported in 0.4% of those taking atomoxetine (5 out of 1,357, including one suicide attempt) and in none of the 851 taking placebo. There were no suicides. All of these cases happened in children aged 6 to 12, and all occurred during the first month of treatment. The label adds that it is unknown whether the risk extends to long-term use.

For adults, the label says a similar analysis did not show an increased risk.

What the warning asks for is close attention, not panic. Anyone 6 or older taking atomoxetine should be watched for suicidal thoughts, worsening symptoms or unusual changes in behavior, especially in the first months and whenever the dose changes. The label also lists anxiety, agitation, panic attacks, irritability, hostility, impulsivity and restlessness among symptoms that have been reported. If any of these appear or worsen, contact the prescriber right away. If someone is in immediate danger in the US, call or text 988, the Suicide and Crisis Lifeline, or call 911.

If depression is already part of your history, the article on ADHD and depression explains how the two overlap, which is useful context for that conversation with your doctor.

Other warnings on the label

Beyond the boxed warning, the label lists several precautions worth knowing in plain terms:

• Liver. Rare cases of serious liver injury, including liver failure, have been reported after approval. Warning signs include itching, dark urine, yellowing of the skin or eyes, pain in the upper right belly, or unexplained flu-like symptoms. These need a call to the doctor and liver tests.
• Heart and blood pressure. Atomoxetine can raise heart rate and blood pressure. These should be checked before starting, after dose increases and from time to time. People with serious heart problems may not be candidates. The article on ADHD medication and heart health goes into this in more depth.
• Bipolar disorder. Before starting, prescribers are told to screen for a personal or family history of bipolar disorder, mania or hypomania, because atomoxetine may trigger a manic episode in people at risk.
• Urination and priapism. Trouble starting urination can happen. A painful erection lasting too long is rare but needs emergency care.
• The capsule. Atomoxetine is an eye irritant, so capsules are meant to be swallowed whole, not opened. If the powder gets in your eye, flush it with water and get medical advice.
• Growth. In children, height and weight should be monitored.

Strattera vs stimulants at a glance

	Atomoxetine (Strattera)	Stimulants (e.g. Adderall, Ritalin)
Drug type	Norepinephrine reuptake inhibitor	Central nervous system stimulant
Controlled substance	No	Yes
Onset	Gradual, over weeks	Same day
Coverage	Can last around the clock	Depends on the formulation
Misuse potential	Not euphoric in an abuse-potential study	Present, which is why they are controlled
Effect size in trials	Better than placebo, smaller than amphetamines	Generally larger
Boxed warning	Suicidal thoughts in pediatric patients	Abuse, misuse and addiction

The question of misuse matters to many people. Separately from atomoxetine, the site has a longer look at whether ADHD medication is addictive.

Anxiety, availability and stopping

Anxiety. Atomoxetine is not approved for anxiety. But in a 12-week trial by Geller and colleagues, children and teens with ADHD and an anxiety disorder who took atomoxetine had fewer ADHD symptoms than those on placebo, and their anxiety scores improved too. The label summarizes this and a second trial as showing that it did not worsen anxiety. For a broader view of medication and anxiety, see what research says about methylphenidate and anxiety.

Availability. Stimulant shortages have been in the news for years. When I checked the FDA drug shortage data on October 23, 2026, atomoxetine was not listed. If you are dealing with a stimulant supply problem, the Adderall shortage guide covers that side, and ADHD medication without insurance looks at cost.

Stopping. The label states that no taper is needed when atomoxetine is discontinued. That makes stopping physically simpler than with some medications, but it is still a decision to make with your prescriber. The article on stopping ADHD medication covers what to think about before you do.

The honest takeaway

Atomoxetine asks for patience. It will not feel like a switch flipping on, and the first weeks may bring more side effects than benefits. For some people that slow, steady effect is exactly the point: no rush, no crash and no controlled-substance paperwork.

For others, a stimulant will simply work better, and the research supports that too. Neither result says anything about you. It only says which tool fits your brain and your life. A broader view of what medication can and cannot do is in ADHD medication: what to expect.

Bring your notes, your questions and your history to your prescriber. That is where this decision belongs.